Cash flow AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:26 2024-09-13 am EDT			5-day change	1st Jan Change
11,928.00 ^GBX	-1.01%		-5.71%	+12.53%

Sep. 13	AstraZeneca, Daiichi Sankyo Breast Cancer Drug Trial Shows 'Substantial Clinical Activity'	MT
Sep. 13	Daiichi, Astra's Enhertu shows clinical activity in brain metastases	AN

46ce5.pLVFYxiUB_-TJmI6an3PLjtxcsr7zxWcaj2W_QBghC8.wd4BEE7xN8-kf1JCAx78GVJFMYu0_Ur2IVPmhVYMtk6JzwgHSaR-rMdwEQ

Published financial data: ASTRAZENECA PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	24.38B	26.62B	37.42B	44.35B	45.81B
Other Revenues, Total	-	-	-	-	-
Total Revenues	24.38B	26.62B	37.42B	44.35B	45.81B
Cost of Goods Sold, Total	4.85B	5.25B	9.8B	8.62B	8.04B
Gross Profit	19.54B	21.37B	27.62B	35.73B	37.77B
Selling General & Admin Expenses, Total	11.38B	11.59B	14.46B	17.47B	18.02B
R&D Expenses	5.35B	6.12B	8.55B	9.53B	10.3B
Other Operating Expenses	-319M	-486M	-207M	-231M	-987M
Other Operating Expenses, Total	16.41B	17.22B	22.81B	26.77B	27.34B
Operating Income	3.13B	4.15B	4.81B	8.96B	10.43B
Interest Expense, Total	-780M	-738M	-776M	-917M	-1.22B
Interest And Investment Income	145M	77M	43M	81M	301M
Net Interest Expenses	-635M	-661M	-733M	-836M	-918M
Income (Loss) On Equity Invest.	-116M	-27M	-64M	-5M	-12M
Currency Exchange Gains (Loss)	-30M	-34M	-20M	-16M	-34M
Other Non Operating Income (Expenses)	-542M	-487M	-478M	-370M	-292M
EBT, Excl. Unusual Items	1.8B	2.94B	3.52B	7.74B	9.18B
Restructuring Charges	-347M	-251M	-1.28B	-717M	-467M
Merger & Related Restructuring Charges	-	-	-2.44B	-3.57B	-137M
Gain (Loss) On Sale Of Investments	-	-	776M	-	-
Gain (Loss) On Sale Of Assets	1.22B	1.06B	509M	216M	292M
Asset Writedown	-1.04B	-252M	-2.07B	-241M	-434M
Legal Settlements	-610M	9M	-48M	-789M	-1.01B
Other Unusual Items	516M	416M	774M	-133M	-520M
EBT, Incl. Unusual Items	1.55B	3.92B	-265M	2.5B	6.9B
Income Tax Expense	321M	772M	-380M	-792M	938M
Earnings From Continuing Operations	1.23B	3.14B	115M	3.29B	5.96B
Net Income to Company	1.23B	3.14B	115M	3.29B	5.96B
Minority Interest	108M	52M	-3M	-5M	-6M
Net Income - (IS)	1.34B	3.2B	112M	3.29B	5.96B
Net Income to Common Incl Extra Items	1.34B	3.2B	112M	3.29B	5.96B
Net Income to Common Excl. Extra Items	1.34B	3.2B	112M	3.29B	5.96B
Per Share Items
Net EPS - Basic	1.03	2.44	0.08	2.12	3.84
Basic EPS - Continuing Operations	1.03	2.44	0.08	2.12	3.84
Basic Weighted Average Shares Outstanding	1.3B	1.31B	1.42B	1.55B	1.55B
Net EPS - Diluted	1.03	2.44	0.08	2.11	3.81
Diluted EPS - Continuing Operations	1.03	2.44	0.08	2.11	3.81
Diluted Weighted Average Shares Outstanding	1.3B	1.31B	1.43B	1.56B	1.56B
Normalized Basic EPS	0.95	1.44	1.55	3.12	3.7
Normalized Diluted EPS	0.95	1.44	1.54	3.1	3.67
Dividend Per Share	2.8	2.8	2.87	2.9	2.9
Payout Ratio	269.06	111.76	3.44K	132.72	75.25
American Depositary Receipts Ratio (ADR)	0.08	0.08	0.08	0.08	0.08
Supplemental Items
EBITDA	5.65B	6.76B	8.62B	13.9B	15.01B
EBITA	4.99B	6.08B	7.89B	13.04B	14.28B
EBIT	3.13B	4.15B	4.81B	8.96B	10.43B
EBITDAR	5.64B	6.76B	8.62B	-	-
Total Revenues (As Reported)	24.38B	26.62B	37.42B	44.35B	45.81B
Effective Tax Rate - (Ratio)	20.74	19.71	143.4	-31.67	13.6
Total Current Taxes	1.31B	971M	1.2B	1.64B	2.44B
Total Deferred Taxes	-988M	-199M	-1.58B	-2.43B	-1.51B
Normalized Net Income	1.23B	1.89B	2.2B	4.83B	5.73B
Interest on Long-Term Debt	22M	21M	22M	24M	33M
Non-Cash Pension Expense	22M	16M	38M	42M	37M
Supplemental Operating Expense Items
Selling and Marketing Expenses	339M	399M	446M	534M	539M
Research And Development Expense From Footnotes	6.13B	6.05B	9.82B	9.84B	11.02B
Net Rental Expense, Total	-2M	-4M	6M	-	-
Imputed Operating Lease Interest Expense	-603K	-1.09M	1.33M	-	-
Imputed Operating Lease Depreciation	-1.4M	-2.91M	4.67M	-	-
Stock-Based Comp., Other (Total)	259M	277M	615M	619M	579M
Total Stock-Based Compensation	259M	277M	615M	619M	579M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	5.37B	7.83B	6.33B	6.17B	5.84B
Short Term Investments	38M	42M	53M	64M	-
Trading Asset Securities, Total	811M	161M	16M	14M	20M
Total Cash And Short Term Investments	6.22B	8.04B	6.4B	6.24B	5.86B
Accounts Receivable, Total	3.58B	3.81B	6.03B	7.21B	8.41B
Other Receivables	1.6B	1.84B	2.76B	2.71B	3.53B
Total Receivables	5.18B	5.65B	8.8B	9.92B	11.94B
Inventory	3.19B	4.02B	8.98B	4.7B	5.42B
Prepaid Expenses	865M	1.74B	1.51B	1.33B	1.62B
Restricted Cash	-	-	-	162M	102M
Other Current Assets, Total	106M	99M	556M	236M	116M
Total Current Assets	15.56B	19.54B	26.24B	22.59B	25.05B
Gross Property Plant And Equipment	15.85B	17.11B	18.5B	17.19B	19.1B
Accumulated Depreciation	-7.52B	-8.19B	-8.32B	-7.74B	-8.6B
Net Property Plant And Equipment	8.34B	8.92B	10.17B	9.45B	10.5B
Long-term Investments	1.51B	1.19B	1.26B	1.14B	1.78B
Goodwill	11.67B	11.84B	20B	19.82B	20.05B
Other Intangibles, Total	20.83B	20.95B	42.39B	39.31B	38.09B
Deferred Tax Assets Long-Term	2.72B	3.44B	4.33B	3.26B	4.72B
Other Long-Term Assets, Total	748M	846M	972M	909M	931M
Total Assets	61.38B	66.73B	105B	96.48B	101B
Liabilities
Accounts Payable, Total	1.77B	2.35B	2.82B	2.55B	3.27B
Accrued Expenses, Total	9.4B	9.69B	12.36B	13.43B	15.74B
Short-term Borrowings	225M	661M	411M	5.31B	5.13B
Current Portion of Long-Term Debt	1.63B	1.57B	2.25B	960M	989M
Current Portion of Leases	188M	192M	233M	228M	271M
Current Income Taxes Payable	1.36B	1.13B	916M	896M	1.58B
Unearned Revenue Current, Total	125M	1.96B	1.18B	269M	251M
Other Current Liabilities	3.41B	2.76B	2.42B	2.65B	3.31B
Total Current Liabilities	18.12B	20.31B	22.59B	26.29B	30.54B
Long-Term Debt	17.89B	19.8B	29.72B	23.91B	22.4B
Long-Term Leases	487M	489M	754M	725M	857M
Unearned Revenue Non Current	50M	38M	26M	14M	7M
Pension & Other Post Retirement Benefits	2.81B	3.2B	2.45B	1.17B	1.52B
Deferred Tax Liability Non Current	2.49B	2.92B	6.21B	2.94B	2.84B
Other Non Current Liabilities	4.94B	4.33B	4.32B	4.37B	3.78B
Total Liabilities	46.78B	51.09B	66.08B	59.42B	61.95B
Common Stock, Total	328M	328M	387M	387M	388M
Additional Paid In Capital	7.94B	7.97B	35.13B	35.16B	35.19B
Retained Earnings	5B	6.44B	3.64B	3.12B	4.52B
Comprehensive Income and Other	-143M	881M	111M	-1.62B	-949M
Total Common Equity	13.13B	15.62B	39.27B	37.04B	39.14B
Minority Interest	1.47B	16M	19M	21M	23M
Total Equity	14.6B	15.64B	39.29B	37.06B	39.17B
Total Liabilities And Equity	61.38B	66.73B	105B	96.48B	101B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.31B	1.31B	1.55B	1.55B	1.55B
ECS Total Common Shares Outstanding	1.31B	1.31B	1.55B	1.55B	1.55B
Book Value / Share	10	11.9	25.34	23.9	25.25
Tangible Book Value	-19.37B	-17.17B	-23.12B	-22.09B	-18.99B
Tangible Book Value Per Share	-14.77	-13.08	-14.92	-14.25	-12.25
Total Debt	20.43B	22.71B	33.36B	31.14B	29.65B
Net Debt	14.21B	14.68B	26.96B	24.89B	23.79B
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.81B	3.23B	2.5B	1.12B	1.48B
Debt Equivalent Oper. Leases	-16M	-32M	48M	-	-
Minority Interest, Total (Incl. Fin. Div)	1.47B	16M	19M	21M	23M
Equity Method Investments, Total	58M	39M	69M	76M	147M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	830M	1.26B	1.76B	1.42B	1.53B
Inventories - Work In Process, Total	1.27B	1.33B	5.22B	1.86B	2.32B
Inventories - Finished Goods, Total	1.09B	1.43B	2.01B	1.41B	1.57B
Land - (BS)	5.53B	5.85B	6.38B	5.44B	6.47B
Machinery, Total	7.38B	7.74B	7.9B	7.56B	8.7B
Full Time Employees	70.6K	76.1K	83.1K	83.5K	89.9K
Accumulated Allowance for Doubtful Accounts (Supple)	21M	23M	23M	59M	45M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	1.34B	3.2B	112M	3.29B	5.96B
Depreciation & Amortization - CF	868M	900M	959M	1.1B	1B
Amortization of Goodwill and Intangible Assets - (CF)	1.86B	1.93B	3.08B	4.08B	3.85B
Depreciation & Amortization, Total	2.73B	2.83B	4.04B	5.18B	4.85B
Amortization of Deferred Charges, Total - (CF)	68M	61M	63M	76M	280M
(Gain) Loss From Sale Of Asset	-1.22B	-1.06B	-513M	-216M	-292M
(Gain) Loss on Sale of Investments - (CF)	-	-	-776M	-	-
Asset Writedown & Restructuring Costs	966M	257M	2.43B	226M	456M
(Income) Loss On Equity Investments - (CF)	116M	27M	64M	5M	12M
Stock-Based Compensation (CF)	-64M	-72M	45M	27M	-71M
Other Operating Activities, Total	-612M	-807M	-1.52B	-2.53B	-1.15B
Change In Accounts Receivable	-898M	-739M	-961M	-1.35B	-1.42B
Change In Inventories	-316M	-621M	1.58B	3.94B	-669M
Change In Accounts Payable	868M	1.72B	1.4B	1.16B	2.39B
Cash from Operations	2.97B	4.8B	5.96B	9.81B	10.34B
Capital Expenditure	-979M	-961M	-1.09B	-1.09B	-1.36B
Sale of Property, Plant, and Equipment	37M	106M	13M	282M	132M
Cash Acquisitions	-709M	-822M	-10.12B	-1.04B	-1.1B
Sale (Purchase) of Intangible assets	595M	-694M	-522M	-1.03B	-2.13B
Investment in Marketable and Equity Securities, Total	125M	2B	605M	-143M	-87M
Other Investing Activities, Total	274M	87M	54M	60M	477M
Cash from Investing	-657M	-285M	-11.06B	-2.96B	-4.06B
Short Term Debt Issued, Total	-	288M	-	74M	161M
Long-Term Debt Issued, Total	500M	2.97B	12.93B	-	3.82B
Total Debt Issued	500M	3.26B	12.93B	74M	3.98B
Short Term Debt Repaid, Total	-516M	-	-276M	-	-
Long-Term Debt Repaid, Total	-1.69B	-1.82B	-5B	-1.52B	-5.21B
Total Debt Repaid	-2.2B	-1.82B	-5.28B	-1.52B	-5.21B
Issuance of Common Stock	3.52B	30M	29M	29M	33M
Common Dividends Paid	-3.59B	-3.57B	-3.86B	-4.36B	-4.48B
Common & Preferred Stock Dividends Paid	-3.59B	-3.57B	-3.86B	-4.36B	-4.48B
Other Financing Activities, Total	4M	-101M	-178M	-1.05B	-886M
Cash from Financing	-1.76B	-2.2B	3.65B	-6.82B	-6.57B
Foreign Exchange Rate Adjustments	5M	12M	-62M	-80M	-60M
Net Change in Cash	552M	2.32B	-1.51B	-55M	-346M
Supplemental Items
Cash Interest Paid	774M	733M	721M	849M	1.08B
Cash Income Tax Paid (Refund)	1.12B	1.56B	1.74B	1.62B	2.37B
Levered Free Cash Flow	6.26B	3.3B	-896M	12.36B	9.5B
Unlevered Free Cash Flow	6.75B	3.76B	-412M	12.94B	10.06B
Change In Net Working Capital	-2.13B	347M	6.52B	-3.59B	-1.52B
Net Debt Issued / Repaid	-1.7B	1.44B	7.65B	-1.44B	-1.23B

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	3.2	4.05	3.5	5.55	6.6
Return on Total Capital	5.58	7.07	5.42	7.95	9.52
Return On Equity %	8.57	20.8	0.42	8.63	15.64
Return on Common Equity	10.43	22.23	0.41	8.62	15.63
Margin Analysis
Gross Profit Margin %	80.12	80.29	73.81	80.57	82.45
SG&A Margin	46.67	43.53	38.65	39.39	39.35
EBITDA Margin %	23.16	25.41	23.03	31.33	32.76
EBITA Margin %	20.45	22.84	21.09	29.41	31.17
EBIT Margin %	12.82	15.58	12.86	20.21	22.78
Income From Continuing Operations Margin %	5.03	11.81	0.31	7.42	13.01
Net Income Margin %	5.47	12.01	0.3	7.41	13
Net Avail. For Common Margin %	5.47	12.01	0.3	7.41	13
Normalized Net Income Margin	5.06	7.1	5.87	10.89	12.51